Pub. Date : 2005 Mar
PMID : 15687480
4 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Clinical trial data support valsartan as an alternative to angiotensin-converting enzyme (ACE) inhibitors in ACE inhibitor-intolerant patients with chronic heart failure. | Valsartan | angiotensin I converting enzyme | Homo sapiens |
| 2 | Valsartan is generally well tolerated, with renal impairment, elevated serum creatinine and potassium levels, and dizziness being the most common adverse effects; consequently, patients experiencing those adverse events while taking ACE inhibitors are likely to experience them with valsartan. | Valsartan | angiotensin I converting enzyme | Homo sapiens |
| 3 | Valsartan is generally well tolerated, with renal impairment, elevated serum creatinine and potassium levels, and dizziness being the most common adverse effects; consequently, patients experiencing those adverse events while taking ACE inhibitors are likely to experience them with valsartan. | Valsartan | angiotensin I converting enzyme | Homo sapiens |
| 4 | CONCLUSIONS: Valsartan is a safe and effective alternative for heart failure patients intolerant of ACE inhibitors. | Valsartan | angiotensin I converting enzyme | Homo sapiens |